20912 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Methods of treating and preventing infections and associated conditions
#902Compositions and methods for treating inflammatory bowel disease and airway inflammation
#903Therapeutic Agent for infections, and treatment method using the same
#904Cupredoxin derived transport agents and methods of use thereof
#905Nucleic acids encoding GAS57 mutant antigens
#906Methods for treating reperfusion injuries using flagellin
#907Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof
#908ZWITTERIONIC IMMUNOMODULATORS FOR THE TEATMENT OF ASTHMA AND ALLERGY
#909Compositions and methods to prevent cancer with cupredoxins
#910Antigen peptide and use thereof
#911COMBINATION OF ADRENERGIC RECEPTOR AGONIST ALPHA-1 OR ALPHA-2, PREFERABLY BRIMONIDINE WITH FILLERS, PREFERABLY HYALURONIC ACID
#912Protein A compositions and methods of use
#913ANTIMICROBIAL PROTEIN COMPOSITIONS AND USES THEREOF
#914Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870
#915Antichlamydial agents
#916Treatment and diagnosis of inflammatory disorders and HIV
#917Novel Therapeutical Tools and Methods for Treating Blindness
#918Endopeptidase and Neurotoxin Combination Treatment of Multiple Medical Conditions
#919Endopeptidase Treatment of Sexual Dysfunction Disorders
#920Endopeptidase Treatment of Cosmesis Disorders
#921Pharmaceutical compositions containing botulinum neurotoxin
#922Compositions and methods for treating bladder cancer
#923Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist
#924Water-soluble drug carrier and process for producing the same
#925Antibiotic, its nucleotide sequence, methods of construction and uses thereof
#926COMPOSITIONS COMPRISING CYCLIC AMP ENHANCERS AND/OR EP LIGANDS, AND METHODS OF PREPARING AND USING THE SAME
#927USE OF A HOLOTOXIN TO REDUCE ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION OF MISFOLDED PROTEINS
#928Compositions and methods to control angiogenesis with cupredoxins
#929Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#930Compositions and methods for treatment of neoplastic disease
#931Methods and compositions for promoting a cell-mediated immune response
#932Reduction In Bacterial Colonization By Administering Bacteriophage Compositions
#933HSP therapy in conjunction with a low antigenicity diet
#934Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
#935FLAGELLIN FUSION PROTEINS AND CONJUGATES COMPRISING PNEUMOCOCCUS ANTIGENS AND METHODS OF USING THE SAME
#936COMBINATION NEISSERIAL COMPOSITIONS
#937Skin permeating and cell entering (SPACE) peptides and methods of use thereof
#938Methods and compositions for bi-specific targeting of CD19/CD22
#939ANTI-MICROBIAL AGENT FROM PAENIBACILLUS SP. AND METHODS AND USES THEREOF
#940Red-shifted opsin molecules and uses thereof
#941Neurotoxins exhibiting shortened biological activity
#942Non-aqueous synthesis of polysaccharide-protein conjugates for vaccines
#943USES OF GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
#944Therapy with enterotoxin to treat ovarian and uterine cancer
#945Treatment of allergic otitis media in mammals with neurotoxins
#946MIR-21 promoter driven targeted cancer therapy
#947Vaccine immunotherapy
#948Targeted delivery of botulinum toxin to the sphenopalatine ganglion
#949Dendritic cell modulation in post-ischemic wounds
#950METHODS OF MODIFYING P53 ACETYLATION AND TREATING CANCER USING AVRA
#951Antibody therapy
#952Systems and methods for delivery of a therapeutic agent
#953HIGHLY SENSITIVE DETECTION METHOD FOR HIGHLY VIRULENT ORAL CAVITY BACTERIA
#954Chimera comprising bacterial cytotoxin and methods of using the same
#955IL-18 RECEPTOR AS A NOVEL TARGET OF REGULATORY T CELLS IN CANCER
#956Non-toxic biofilm inhibitor
#957Composition for preventing virus infection comprising poly-gamma-glutamic acid
#958Flagellin related polypeptides and uses thereof
#959Flagellin related polypeptides and uses thereof
#960Synthetic antigenic peptides and lipopeptides derived from subsp.
#961Secretion System and Methods for its Use
#962DRUG FOR TREATING INFECTIONS
#963Methods of Treating Tumor Cells Using RHCC Protein, Fragment or Variant
#964Immunogenic heat stable enterotoxin
#965Compounds
#966IMMUNOSTIMULATORY COMBINATIONS
#967Commensal bacteria as signal mediators within a mammalian host
#968Nisin derivatives and the use thereof
#969Combination therapy to combat helminth resistance
#970Method for treating prostatitis utilizing modified pore-forming protein proaerolysin
#971Methods of protecting against apoptosis using lipopeptides
#972Compositions and methods for the removal of biofilms
#973Anticancer agent
#974Methods for the treatment of graft-versus-host disease
#975TREATMENT OF METASTATIC COLON CANCER WITH B-SUBUNIT OF SHIGA TOXIN
#976Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen
#977METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE
#978Skin treatment compositions
#979Antibody therapy
#980YopM as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions
#981ANTIVIRAL ACTIVITY OF THE PROTEIN SCYTOVIRIN AND METHODS OF USE
#982Methods of treating inflammatory intestinal disease and managing symptoms thereof
#983Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870
#984Light-Activated Proton Pumps and Applications Thereof
#985COMPOSITION FOR MUCOSAL ADMINISTRATION CONTAINING AGENT FOR ENHANCING MUCOSAL ABSORPTION OF PEPTIDE DRUG, AND ADMINISTRATION METHOD THEREOF
#986METHOD OF REDUCING MOTILITY IN BACTERIA BY OVEREXPRESSION OF A GENE OF OI-1 GENOMIC ISLAND
#987Pharmaceutical compositions containing botulinum toxin
#988Treatment of sinusitis in mammals with clostridia neurotoxins
#989Methods for treating reperfusion injuries using flagellin
#990Immunotherapies employing self-assembling vaccines
#991Biotechnological production of cyanophycin dipeptides
#992GAS57 mutant antigens and GAS57 antibodies
#993Use of polypeptides having antimicrobial activity
#994METHODS AND COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS
#995Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors
#996COMBINATION NEISSERIAL COMPOSITIONS
#997Vaccine for the treatment of related disorders
#998Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells
#999Treatment of asthma in mammals with clostridia neurotoxins
#1000Treatment of allergic rhinitis in mammals with neurotoxins
#1001Treatment of infectious rhinitis in mammals with clostridia neurotoxins
#1002Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#1003METHODS OF TREATING CANCER USING NEUROTROPHIN RETARGETED ENDOPEPTIDASES
#1004Methods of Treating Cancer Using Galanin Retargeted Endopepidases
#1005Protein A compositions and methods of use
#1006ZWITTERIONIC IMMUNOMODULATORS FOR THE TREATMENT OF ASTHMA AND ALLERGY
#1007Protein delivery system to generate pluripotent stem (iPS) cells or tissue specific cells
#1008Multicomponent meningococcal vaccine
#1009TYPE A2 BOTULINUM TOXIN PREPARATION
#1010Human monoclonal antibodies specific for CD22
#1011Antimicrobial Composition and Method for Use
#1012Ex vivo uses of immunostimulatory combinations
#1013PROTEIN-ASSISTED DRUG DELIVERY SYSTEM FOR THE TARGETED ADMINISTRATION OF ACTIVE AGENTS
#1014Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#1015T CELL DEPLETING COMPOSITIONS USEFUL FOR TREATING CANCER
#1016RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS
#1017METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE AND PATHOGENIC DISEASES
#1018METHOD FOR THE INTERNALIZATION OF NON-INVASIVE BACTERIA IN EUKARYOTE CELLS
#1019COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE AND METHODS OF TREATING CANCER USING COMPOSITIONS THEREOF
#1020Method for inducing lymphoid tissue and modulating intestinal homeostasis
#1021Modifications of cupredoxin derived peptides and methods of use thereof
#1022Macrocyclic lactone combination compositions, vaccines and methods for producing same
#1023Treatment of malodour
#1024Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin
#1025Diphtheria toxin first open reading frame operably linked to an H19 promoter and a diphtheria toxin second open reading frame operably linked to an IGF-II promoter as nucleic acid construct
#1026COMPOSITION FOR PREVENTING VIRUS INFECTION COMPRISING POLY-GAMMA-GLUTAMIC ACID
#1027ANTI-H5N1 INFLUENZA ACTIVITY OF THE ANTIVIRAL PROTEIN CYANOVIRIN
#1028Modified bacteriophage including an alpha/beta small acid-soluble spore protein (SASP) gene
#1029Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins
#1030Targeted delivery of botulinum toxin to the sphenopalatine ganglion
#1031Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#1032Antibody therapy
#1033Treating neoplasms with neurotoxin
#1034Drug for suppressing pathogen occurring in vivo
#1035Cupredoxin derived transport agents and methods of use thereof
#1036Modulators of the ABC transporter family and methods for their use
#1037Intrathecal and intratumoral superantigens to treat malignant disease
#1038HUMAN CANCER THERAPY USING ENGINEERED MATRIX METALLOPROTEINASE-ACTIVATED ANTHRAX LETHAL TOXIN THAT TARGETS TUMOR VASCULATUTURE
#1039USE OF TETANUS TOXIN TO AMPLIFY INADEQUATE VOLUNTARY MUSCLE CONTRACTION OR TO IMPROVE MUSCLE TONE IN AN ANIMAL ACTIVELY VACCINATED AGAINST THE TOXIN AND A REGIMEN FOR TREATMENT
#1040Methods of Inhibiting Metastatic Cancer by Administration of Streptolysin O
#1041Fusion proteins of collagen-binding domain and parathyroid hormone
#1042Modulating apoptosis
#1043METHODS FOR REDUCING OR PREVENTING TRANSMISSION OF NOSOCOMIAL PATHOGENS IN A HEALTH CARE FACILITY
#1044Use of flagellin to prevent and treat gram negative bacterial infection
#1045USE OF POLYPEPTIDES AS COCCIOSTAT AND/OR HISTOMONASTAT
#1046Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease
#1047Compositions and methods to prevent cancer with cupredoxins
#1048Detection and therapy of bacterial infection caused by
#1049BLEOMYCIN PREPARATION FOR USE AGAINST SKIN TUMOURS
#1050COMBINATION WITH BIS (THIOHYDRAZIDE AMIDES) FOR TREATING CANCER
#1051Method for screening modulators of apoptosis
#1052Bacterial-derived BLIS for treatment of acne
#1053METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS
#1054Uses of antimicrobial genes from microbial genome
#1055METHOD FOR REDUCING SPASMS COMPRISING TREATMENT WITH AN AGENT THAT ELEVATES THE LEVEL OF ONE OR MORE CYCLIC NUCLEOTIDES IN THE MUSCLE
#1056Synthetic LDL as targeted drug delivery vehicle
#1057Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases
#1058Compositions and methods to control angiogenesis with cupredoxins
#1059RNAi methods and compositions for stimulating proliferation of cells with adherent junctions
#1060Systems and methods for delivery of a therapeutic agent
#1061Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#1062Colicinogenic strain of
#1063Use of Trap Protein Per se as an Active Ingredient for the Manufacture of a Medicament for the Treatment of Staphylococcus Aureus Infection
#1064Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis
#1065COMPOSITIONS AND METHODS FOR TREATING BACTERIA
#1066GENE EXPRESSED IN PROSTATE CANCER AND METHODS OF USE
#1067Treatment of metastatic tumors
#1068Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer
#1069Modified cupredoxin derived peptides
#1070CLOSTRIDIUM BOTULINUM C3 EXOTRANSFERASE COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING
#1071USE OF INTERLEUKIN-19 TO TREAT CERVICAL CANCER
#1072Compositions of active Wnt protein
#1073Therapeutic agent for infections, and treatment method using the same
#1074Pharmaceutical use of protein molecules immunologically correlated to diptheria toxin
#1075Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
#1076Method of modulating neovascularization
#1077Method for reducing the effects of chemotherapy using flagellin related polypeptides
#1078THERAPEUTIC USE OF SCIN, A STAPHYLOCOCCAL COMPLEMENT INHIBITOR IN INFLAMMATORY DISEASES
#1079NOVEL ANTIBIOTIC ALTERNATIVES
#1080Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation
#1081Use of outer membrane protein A (OMPA) in treatment/prevention/diagnosis of infections caused by and other gram-negative bacteria
#1082Therapeutic treatments using botulinum neurotoxin
#1083Methods for treating acute myeloid leukemia with diphtheria toxin-interleukin-3 conjugates
#1084Method or agent for inhibiting the function of efflux pump
#1085Compositions and methods to prevent cancer with cupredoxins
#1086Surface-layer protein coated microspheres and uses thereof
#1087OMP P6 VACCINE FOR TREATING AND PREVENTING CHLAMYDIA INFECTION
#1088Methods of protecting against apoptosis using lipopeptides
#1089CYTOTOXIC PROTEIN AND UTLIZATION THEREOF
#1090N-acylated chitinous polymers and methods of use thereof
#1091CELL-SURFACE DECORATION WITH ACTIVE AGENTS
#1092Cytolethal distending toxin and use thereof
#1093Compositions and methods for treating bacteria
#1094METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
#1095Methods And Compositions For Modulating An Immune Response
#1096COMPOSITIONS, METHODS AND USES FOR A NOVEL FAMILY OF PEPTIDES
#1097HSP THERAPY IN CONJUNCTION WITH A LOW ANTIGENICITY DIET
#1098Enterotoxin gene cluster (egc) superantigens to treat malignant disease
#1099Modified Cyanovirin-N Polypeptide
#1100Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer
#1101Compositions and methods for facilitating heme-iron export from cells
#1102Multicomponent meningococcal vaccine
#1103Lactobacilli expressing biologically active polypeptides and uses thereof
#1104COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING
#1105Use of polypeptides having antimicrobial activity
#1106TLR9 agonist and CD40 agonist immunostimulatory combinations
#1107Compositions and methods for treatment of neoplastic disease
#1108TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASES
#1109Recombinant adenylate cyclase toxin of induces T cell responses against tumoral antigens
#1110Therapeutic agent for cancer
#1111Method for the inhibition of angiogenesis or cancer using protective antigen related molecules
#1112Antibody therapy
#1113Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells
#1114Bioactive molecular matrix and methods of use in the treatment of disease
#1115HUMAN THERAPIES USING CHIMERIC AGONISTIC ANTI-HUMAN CD40 ANTIBODY
#1116COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING GASTROENTERIC DISEASES
#1117Reduction in bacterial colonization by administering bacteriophage compositions
#1118ANTIBACTERIAL AGENT
#1119Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
#1120Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
#1121Method for inhibiting infection and reproduction of influenza type A WSN virus
#1122Treating neoplasms with neurotoxin
#1123Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
#1124Flagellin related polypeptides and uses thereof
#1125Anti-malaria vaccine
#1126Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
#1127PROTEIN CAGE IMMUNOTHERAPEUTICS
#1128Development of Novel Antibiotic Alternatives
#1129Methods of Identifying Agents Having Antiangiogenic Activity
#1130Non-toxic biofilm inhibitor
#1131INHIBITION OF YERSINIA PESTIS
#1132Targeted delivery of botulinum toxin to the sphenopalatine ganglion
#1133COMPOSITIONS AND METHODS FOR USING SYRINGOPEPTIN 25A AND RHAMNOLIPIDS
#1134Blue-green algae composition
#1135Compositions and methods for modulating an immune response
#1136Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
#1137USE OF A COMPOSITION
#1138CYTOTONIC PROTEIN AND UTLIZATION THEREOF
#1139Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabilized with Polypeptide Fragments Derived from HIV-TAT
#1140Phage Screening Assay
#1141Methods of identifying a compound that increases or decreases the interaction of Hn-33 with synaptotagmin II
#1142Compositions and methods to prevent cancer with cupredoxins
#1143Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
#1144METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF STAPHYLOCOCCAL INFECTIONS
#1145Therapeutic compositions
#1146Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#1147Agent for treating allergic or hypersensitivity condition
#1148Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#1149METHOD OF TREATING PULMONARY FIBROSIS
#1150Cytotoxic factors for modulating cell death
#1151Tumor cell vaccines
#1152Process for production of diphtheria toxin
#1153Compositions and methods to prevent cancer with cupredoxins
#1154TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING LANTIBIOTIC CONTAINING COMPOSITIONS
#1155Methods for treating myelodysplastic syndrome with a human interleukin-3-diphtheria toxin conjugate
#1156RS7 antibodies
#1157Methods and Compositions for Treating Tumors
#1158PHARMACEUTICAL COMPOSITIONS CONTAINING BOTULINUM TOXIN
#1159Selection and use of lactic acid bacteria for reducing inflammation in mammals
#1160Compositions and methods to control angiogenesis with cupredoxins
#1161CHLAMYDIA VACCINES
#1162Thermographic Assessment Of Clostridial Toxin Applications
#1163Targeted delivery of cytotoxic drugs A) to activated lymphocytes in patients iwth transplanted organs, B) as radiosensitizers to cancer cells in paients undergoing radiation therapy, and C) in vitaminpbinding proteins as drug carriers in the diagnosis and treatment of cancer
#1164Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
#1165Human papilloma virus treatment
#1166Fusion proteins comprising flagellin and dengue viral envelope proteins
#1167Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
#1168TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASES
#1169Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading
#1170ADENOVIRUS FIBER SHAFT COMPOSITION AND METHODS OF USE
#1171Proteins Involved In Quorum Sensing
#1172Modulators of the ABC Transporter Family and Methods for Their Use
#1173Compositions of active Wnt protein
#1174USE OF INTERLEUKIN-19 TO TREAT CERVICAL CANCER
#1175NOVEL NANOPARTICLES AND USE THEREOF
#1176Compositions and methods for activating Toll-like receptor 4
#1177Neutralization of bacterial spores
#1178Combination neisserial compositions
#1179Method of treatment of tendonitis by administration of streptolysin O
#1180Method of enhancing degradation of chitin
#1181Recombinant Alkalinizing Bacteria
#1182Rhamnolipid compositions and related methods of use
#1183Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties
#1184METHOD FOR THE PRODUCTION OF PURIFIED INVASIN PROTEIN AND USE THEREOF
#1185ANTIBODY THERAPY
#1186Crystals of LuxP and complexes thereof
#1187Compositions and methods for treating bacteria
#1188Polypeptide absorbable into digestive organs
#1189METHOD FOR TREATING INFLAMMATORY DISEASES USING HEAT SHOCK PROTEINS
#1190ORAL ANTIMICROBIAL COMPOSITION
#1191Modified SEB and prophylactics/remedies for immunopathy containing the same
#1192Verotoxin pharmaceutical compositions and medical treatments therewith
#1193Protein A compositions and methods of use
#1194Probiotic compounds from Lactobacillus GG and uses therefor
#1195Defensin-inducing agents
#1196Lactobacilli expressing biologically active polypeptides and uses thereof
#1197Compositions of active Wnt protein
#1198Modulators of the abc transporter family and methods for their use
#1199Methods and compositions for the prevention and regression of neovascularization
#1200Inhibition of inward sodium currents in cancer